Cargando…

Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma

BACKGROUND: Different theories have been postulated to explain the development of nodular prostatic hyperplasia (NPH). Epithelial to mesenchymal transition (EMT) is a physiologic process in which the epithelial cells lose their polarity and cell-cell adhesion and acquire a mesenchymal phenotype. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdallah, Rania Abdallah, Abdou, Asmaa Gaber, Abdelwahed, Moshira, Ali, Hend
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442322/ https://www.ncbi.nlm.nih.gov/pubmed/31008053 http://dx.doi.org/10.4103/JMAU.JMAU_46_18

Ejemplares similares

Renal Cell Carcinoma With Rhabdoid and Sarcomatoid Features Presented as a Metastatic Thigh Mass With an Unusual Immunohistochemical Profile
por: Abdou, Asmaa Gaber, et al.
Publicado: (2014)

Gene Expression of Aurora Kinases in Prostate Cancer and Nodular Hyperplasia Tissues
por: Nna, Emmanuel, et al.
Publicado: (2013)

Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia
por: Gangkak, Goto, et al.
Publicado: (2017)

Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma
por: Rajkumar, Sharmilla Devi, et al.
Publicado: (2021)

Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma
por: Eldien, Marwa Mohammed Serag, et al.
Publicado: (2017)

Immunohistochemical Observation of Co-expression of E- and N-cadherins in Rat Organogenesis
por: Sakamoto, Atsushi, et al.
Publicado: (2008)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

AB012. E-cadherin is down-regulated in benign prostate hyperplasia and required for tight junction formation and permeability barrier in prostatic epithelial cell monolayer
por: Li, Feng, et al.
Publicado: (2018)

Expression of e-cadherin, n-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt
por: ElMoneim, Hanan Mohamed Abd, et al.
Publicado: (2011)

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019)

Focal nodular hyperplasia of the liver
por: Geller, Stephen A., et al.
Publicado: (2014)

Evaluation of immunohistochemical expression of E-cadherin in pleomorphic adenoma and adenoid cystic carcinoma
por: Sangala, Bhavani Nagendra, et al.
Publicado: (2022)

Immunohistochemical Expression of E-Cadherin and β-Catenin in Oral Squamous Cell Carcinoma
por: Akinyamoju, Akindayo Olufunto, et al.
Publicado: (2023)

Microvascular density and immunohistochemical expression of VEGF, VEGFR-1 and VEGFR-2 in benign prostatic hyperplasia, high-grade prostate intraepithelial neoplasia and prostate cancer
por: Grivas, Nikolaos, et al.
Publicado: (2016)

Ergonomics and musculoskeletal symptoms in surgeons performing endoscopic procedures for benign prostatic hyperplasia
por: Omar, Mohamed, et al.
Publicado: (2020)

Tumour-infiltrating Langerhans cells in non-melanoma skin cancer, a clinical and immunohistochemical study
por: Maraee, Alaa, et al.
Publicado: (2020)

Friend or foe: role of E-cadherin in prostate cancer metastasis
por: Lin, Ching-Yu, et al.
Publicado: (2016)

The absence of early malignant changes in women subjected to Aquafilling breast augmentation on the basis of E-cadherin and N-cadherin immunohistochemical expression
por: Chalcarz, Michał, et al.
Publicado: (2023)

Cytomorphology of nodular histiocytic/mesothelial hyperplasia
por: Jin, Xiaobing, et al.
Publicado: (2022)

Correlation of E-cadherin Immunohistochemical Expression with Histopathological Grading of Oral Squamous Cell Carcinoma
por: Kushwaha, Sandhya Singh, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia
Publicado: (2015)

Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens
por: Abdou, Asmaa Gaber, et al.
Publicado: (2019)

Slug, Twist, and E-Cadherin as Immunohistochemical Biomarkers in Meningeal Tumors
por: Nagaishi, Masaya, et al.
Publicado: (2012)

Immunohistochemical Expression of MMP-9 and E-Cadherin in subtypes of Ameloblastoma
por: Farhan, Farah, et al.
Publicado: (2022)

Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma
por: Oh, Woo Jin, et al.
Publicado: (2016)

Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
por: Yates, C C, et al.
Publicado: (2007)

Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma
por: Alaiya, Ayodele, et al.
Publicado: (2000)

Maspin Expression in Epithelial Skin Tumours: An Immunohistochemical Study
por: Abdou, Asmaa Gaber, et al.
Publicado: (2011)

E-Cadherin Downregulation is Mediated by Promoter Methylation in Canine Prostate Cancer
por: Fonseca-Alves, Carlos Eduardo, et al.
Publicado: (2019)

The role and relationship between programmed death ligand 1 and cytotoxic T lymphocyte-associated antigen-4 immunohistochemical expression in colorectal carcinoma patients: an impact on outcome
por: El Dein Mohameda, Asmaa Shams, et al.
Publicado: (2021)

Inflammation in Prostatic Hyperplasia and Carcinoma—Basic Scientific Approach
por: Krušlin, Božo, et al.
Publicado: (2017)

Analysis of Melatonin-Modulating Effects Against Tartrazine-Induced Neurotoxicity in Male Rats: Biochemical, Pathological and Immunohistochemical Markers
por: Essawy, Amina E., et al.
Publicado: (2022)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

Laparoscopic Partial Hepatectomy of Focal Nodular Hyperplasia
por: Sakata, Mayu, et al.
Publicado: (2012)

An elderly man with progressive focal nodular hyperplasia
por: Hamada, Koichi, et al.
Publicado: (2019)

Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
por: Lanis, Aviya, et al.
Publicado: (2022)

Nodular Lymphoid Hyperplasia in Children: Recurrent Hematemesis
por: Che Husin, Nurfariza, et al.
Publicado: (2023)

Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia
por: Filipovski, Vanja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4vapfp33oq3m1pn5ngoog2j3qk